Marcel van den Brink appointed president, chief physician executive of City of Hope Los Angeles & National Medical Center

City of Hope receives $100M gift from Panda Express founders to create national integrative oncology program

City of Hope received a $100 million gift from Andrew and Peggy Cherng, philanthropists, co-founders and co-CEOs of Panda Express, to create a first-of-its-kind, national integrative oncology program that brings together Eastern and Western medicine to improve outcomes and quality of life for cancer patients and survivors.

September 15, 2023

Vol.49 No.34

Clinical Roundup

City of Hope researchers identify biomarkers that may detect risk of advanced prostate cancer in Black men

Scientists at City of Hope have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments for Black men with these diseases.

September 08, 2023

Vol.49 No.33

Conversation with The Cancer Letter

Steve Rosen reads his poems—and tells us why he writes

Fifteen years ago, after the death of his favorite uncle, Steven Rosen committed his grief to paper.

City of Hope receives $32.3M from CIRM

Researchers at City of Hope were awarded $32.3 million from the California Institute for Regenerative Medicine to support three novel phase I clinical trials evaluating innovative cell and gene therapy treatments for patients with acute myeloid leukemia and other diseases.

August 11, 2023

Vol.49 No.32

Clinical Roundup

City of Hope researchers develop a CAR T-cell therapy for advanced ovarian cancer, now in phase I

City of Hope researchers published preclinical research in Nature Communications demonstrating that a CAR-engineered T-cell therapy worked against ovarian cancer in the laboratory and in preclinical models.

August 11, 2023

Vol.49 No.32

In Brief

David W. Craig named founding chair of Department of Integrative Translational Sciences at City of Hope

David W. Craig was named professor and inaugural founding chair of Department of Integrative Translational Sciences within Beckman Research Institute of City of Hope. Craig was also named deputy director of translational sciences at Beckman Research Institute and associate director of data science for City of Hope’s NCI-designated comprehensive cancer center in Los Angeles.

July 07, 2023

Vol.49 No.27

Marcel van den Brink appointed president, chief physician executive of City of Hope Los Angeles & National Medical Center

YOU MAY BE INTERESTED IN

City of Hope receives $100M gift from Panda Express founders to create national integrative oncology program

City of Hope researchers identify biomarkers that may detect risk of advanced prostate cancer in Black men

Steve Rosen reads his poems—and tells us why he writes

City of Hope receives $32.3M from CIRM

City of Hope researchers develop a CAR T-cell therapy for advanced ovarian cancer, now in phase I

David W. Craig named founding chair of Department of Integrative Translational Sciences at City of Hope

Renew today!

Subscriber content

Login